Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 SEK | +3.14% | -2.82% | +11.65% |
May. 21 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 08 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.84M | - | - | - | - | - | |
791B | ||||||
630B | ||||||
350B | - | - | - | - | ||
328B | ||||||
298B |
- Stock Market
- Equities
- ONCOZ Stock
- Charts OncoZenge AB
- Sector Chart